Freeman Kevin Lee 4
4 · Health Catalyst, Inc. · Filed Dec 3, 2024
Insider Transaction Report
Form 4
Freeman Kevin Lee
Chief Commercial Officer
Transactions
- Sale
Common Stock
2024-12-02$8.94/sh−7,500$67,073→ 236,950 total - Tax Payment
Common Stock
2024-12-01$8.97/sh−11,431$102,573→ 244,450 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1.